List of works - Fiona Thistlethwaite

A Phase II Multicentre, Open-Label, Proof-of-Concept Study of Tasquinimod in Hepatocellular, Ovarian, Renal Cell, and Gastric Cancers

scientific article published on 01 October 2017

Adoptive transfer of T(reg) depleted autologous T cells in advanced renal cell carcinoma.

scientific article published on 27 September 2007

Cellular therapy of cancer symposium December 2nd-3rd 2006 Manchester, UK

scientific article published on 27 February 2007

Definition and application of good manufacturing process-compliant production of CEA-specific chimeric antigen receptor expressing T-cells for phase I/II clinical trial.

scientific article

Delivery of adoptive cell therapy in the context of the health-care system in the UK: challenges for clinical sites

scientific article published on 20 September 2020

Discovery and Evaluation of Protein Biomarkers as a Signature of Wellness in Late-Stage Cancer Patients in Early Phase Clinical Trials

scientific article published in 2021

First generation anti-CD19 chimeric antigen receptor-modified T cells for management of B cell malignances: initial analysis of an ongoing Phase I clinical trial

High-dose interleukin-2 (hd-IL2) in treatment-naïve metastatic renal cell carcinoma (mrcc) - a 10 year single-site experience and outcome of prospective pathology-based patient selection.

scientific article published on 6 November 2014

High-dose interleukin-2 can produce a high rate of response and durable remissions in appropriately selected patients with metastatic renal cancer

scientific article published on 01 January 2011

High-dose interleukin2 - a 10-year single-site experience in the treatment of metastatic renal cell carcinoma: careful selection of patients gives an excellent outcome.

scientific article published on 18 October 2016

Immunohistochemical assessment of NY-ESO-1 expression in esophageal adenocarcinoma resection specimens

scientific article published on April 2014

Involvement of Brca2 in DNA Repair ⬇️

scientific article published on February 1, 1998

Mitotic checkpoint inactivation fosters transformation in cells lacking the breast cancer susceptibility gene, Brca2.

scientific article published in July 1999

Modulation of lymphocyte regulation for cancer therapy: a phase II trial of tremelimumab in advanced gastric and esophageal adenocarcinoma.

scientific article published on 23 February 2010

The clinical efficacy of first-generation carcinoembryonic antigen (CEACAM5)-specific CAR T cells is limited by poor persistence and transient pre-conditioning-dependent respiratory toxicity

scientific article published on 28 June 2017

Tremelimumab (anti-CTLA4) mediates immune responses mainly by direct activation of T effector cells rather than by affecting T regulatory cells

scientific article published on 5 November 2010

Vaccination of patients with metastatic renal cancer with modified vaccinia Ankara encoding the tumor antigen 5T4 (TroVax) given alongside interferon-alpha

scientific article published in May 2009

Weekly paclitaxel in the treatment of recurrent ovarian carcinoma

scientific article published on 01 January 2007

List of works by Fiona Thistlethwaite